| dbo:assets
|
- 2413.0 (dbd:usDollar)
- 2715.0 (dbd:usDollar)
|
| dbo:description
|
- شركة أيرلندية (ar)
- Irish tax-registered pharmaceutical (en)
- irisches Unternehmen der pharmazeutischen Industrie (de)
|
| dbo:foundingYear
| |
| dbo:headquarter
| |
| dbo:industry
| |
| dbo:keyPerson
| |
| dbo:netIncome
| |
| dbo:numberOfEmployees
|
- 3103 (xsd:nonNegativeInteger)
|
| dbo:operatingIncome
| |
| dbo:predecessor
| |
| dbo:product
| |
| dbo:revenue
|
- 2903.0 (dbd:usDollar)
- 2993.0 (dbd:usDollar)
|
| dbo:thumbnail
| |
| dbo:type
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageWikiLink
| |
| dbp:assets
|
- (en)
- USD 2,413 million (en)
- USD 2,715 million (en)
|
| dbp:footnotes
| |
| dbp:hqLocation
|
- * Dublin, Ireland
* Malvern, Pennsylvania, United States. (en)
|
| dbp:industry
| |
| dbp:isin
| |
| dbp:keyPeople
|
- (en)
- Blaise Coleman (en)
- Paul Campanelli (en)
|
| dbp:logo
|
- Endo Pharmaceuticals Logo.png (en)
|
| dbp:name
|
- Endo International plc (en)
|
| dbp:netIncome
|
- (en)
- 1.84E8 (dbd:usDollar)
- -6.13E8 (dbd:usDollar)
|
| dbp:numEmployees
| |
| dbp:operatingIncome
|
- (en)
- -2.7E7 (dbd:usDollar)
- -5.47E8 (dbd:usDollar)
|
| dbp:predecessor
|
- Endo Pharmaceuticals Inc. (en)
|
| dbp:products
|
- (en)
- Adrenalin (en)
- Percocet (en)
- Supprelin LA (en)
- Testopel (en)
- Vasostrict (en)
- Xiaflex (en)
|
| dbp:revenue
|
- (en)
- USD 2,903 million (en)
- USD 2,993 million (en)
|
| dbp:secCik
| |
| dbp:type
| |
| dbp:wikiPageUsesTemplate
| |
| dct:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:label
|
- Endo International (en)
- Endo International (de)
- Endo (entreprise) (fr)
- Endo International (ru)
|
| rdfs:seeAlso
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Endo International plc (en)
|
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
